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Introduction
Neurosurgical conditions such as head injury, intracra-
nial hemorrhage (ICH), brain neoplasm, stroke and so
on usually require intensive care. Due to advances in the
modern critical care system, decision-making in how
intensive care facilities should be used is necessary.1
Mortality prediction models can evaluate the severity of
disease and allow for proper allocation of resources.2
The 2 most popular mortality prediction models are the
Acute Physiology and Chronic Health Evaluation II
(APACHE II) proposed by Knaus et al in 1985,3 and
the Simplified Acute Physiology Score II (SAPS II) pro-
posed by Le Gall et al in 1993.4 For many diseases, both
models can predict the probability of mortality.5–7
Some research has indicated that SAPS II performs
better than APACHE II for certain diseases,8,9 while
other research has demonstrated that APACHE II is
better than SAPS II for other diseases.2,10,11 Alvarez
et al12 reported that SAPS II and APACHE II show a
less than satisfactory calibration in head injury patients.
Another report shows poor prediction in patients with
low risk and patients who have lower tendency to
mortality, even though the models were calibrated.13
Capuzzo et al14 reported that SAPS II overestimated
mortality in patients at high risk for mortality, whereas
APACHE II underestimated mortality in such patients.
The Glasgow Coma Scale (GCS) is one of the most
important evaluation systems used to assess patient con-
sciousness.15 Some research has demonstrated that the
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GCS can be a good indicator for the outcome of dis-
eases, especially neurosurgical diseases.16–18 Many mor-
tality prediction models include the component of
GCS.3,4 Recently, GCS was used for prognostic factor
evaluation of patients with acute community-acquired
bacterial meningitis.17 However, the GCS cannot pre-
dict the probability of mortality. Instead, it only scores
patients’ degree of disease severity.
Some studies have evaluated the mortality rates of
head injury patients using mortality prediction sys-
tems.12,19 However, there is no report that focuses on
mortality prediction for neurosurgical diseases. In this
study, we demonstrated the power of probabilistic pre-
diction models of APACHE II, SAPS II and GCS in
neurosurgical patients.
Methods
We recorded 161 patients’ data with neurosurgical dis-
eases in the intensive care unit (ICU) of a 600-bed gen-
eral hospital from January 2000 to August 2001. Seven
patients were excluded from this study because they
were younger than 18 years old. Both APACHE II and
SAPS II scores in these 154 patients were analyzed.
The GCS data of patients were included in both mor-
tality models. A multiple linear regression model of
GCS (GCS-mr) was built using the eye component of
GCS (GCS-E), the verbal component of GCS (GCS-V)
and the motor component of GCS (GCS-M) as the
independent variables, and the probability of mortality
was the dependent variable. The patients’ probabilities
of mortality were also analyzed. Patients were classified
as dead if they died in hospital or within 24 hours of
being discharged, and the probability of mortality of
these patients was defined as 1. Patients were classified
as alive if they were still alive at least 3 months after their
ICU admission, and the probability of mortality of
these patients was defined as 0.
There are 3 admission types according to the SAPS
II definition: medical problems, scheduled surgery and
emergency surgery. The definition of medical problems
is when patients are admitted to the ICU due to their
medical problems. The definition of scheduled surgery
is when patients are admitted to the ICU with scheduled
surgery but their conditions are ones of high risk. The
definition of emergency surgery is when patients have
undergone high-risk emergent surgery and need further
intensive care.
This study used the disease classification system in
APACHE II. Diseases were classified into 7 groups
(Table 1). These included patients admitted to the
ICU due to ICH, subdural hemorrhage (SDH) and 
subarachnoid hemorrhage (SAH) with or without sur-
gery. Some patients could not be accurately diagnosed
before discharge or death and were therefore classified
as “non-classified neurological disease”. Patients with
brain tumors were also classified into this group if they
did not receive craniotomy. Some patients were found
to have neurological organ failure with unstable vital
signs, and were often classified into the “neurological
organ failure” group. Some patients suffered head in-
jury but no ICH, SDH or SAH were found. Thus, they
were classified into the “head trauma” group. Patients
with more than 2 injured organs and a major head in-
jury were classified into the “multiple trauma” group.
The predicted percentages of mortality using the
APACHE II and SAPS II scoring systems were calcu-
lated. The coefficients of correlations of these 2
prediction models with GCS were also calculated.
The receiver operating characteristic (ROC) curve
was used to evaluate the accuracy of prediction, which
is defined as good or excellent if the area under 
the ROC curve (AUC) is > 0.8.20 The ROC curve,
multiple linear regression and coefficient of correla-
tion were calculated using SPSS version 10.0 (SPSS
Inc., Chicago, IL, USA).
Results
The demographic characteristics of the 154 patients (50
female, 104 male) are shown in Table 1; 108 patients
survived (53.11 ± 21.65 years old) and 46 patients died
(59.59±19.73 years old). The majority of patients were
admitted to the ICU for medical problems (54.89 ±
20.77 years old), followed by admission for scheduled
surgery (57.41 ± 20.95 years old) and then emergency
surgery (52.00 ± 23.13 years old). Almost half of the
patients were admitted to the ICU due to ICH, SDH
and SAH without surgery (58.98 ± 16.66 years old) or
with surgery (54.05 ± 21.56 years old). Twenty-seven
patients were classified into the “non-classified neuro-
logical disease” group (65.00 ± 22.90 years old), and
6 patients were classified into the “neurological organ
failure” group (68.00±16.65 years old). Almost a third
of patients had head trauma (42.47 ± 22.10 years old)
or multiple trauma (47.00 ± 23.78 years old). Only 7
patients were admitted to the ICU because of surgery
for brain tumor (53.57 ± 17.89 years old).
The AUCs of SAPS II and APACHE II were
0.872 and 0.846, respectively. There was no signifi-
cant difference in performance between SAPS II and
APACHE II (p = 0.537). To find a better scoring sys-
tem, we also used GCS-E, GCS-V and GCS-M to-
gether as independent factors to build a multiple linear
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regression model of GCS (GCS-mr). The AUC of
GCS-mr was 0.866 (R2 =0.389). The prediction power
of GCS-mr was the same as that of SAPS II (p=0.883)
and APACHE II (p=0.657) (Figure 1). The functions
of GCS-mr are:
GCS-mr = 0.873 − 0.0721 × (GCS-E) + 0.0546 ×
(GCS-V) − 0.137 × (GCS-M)
GCS is an important factor in most mortality pre-
diction models. We thus evaluated the performance of
SAPS II and APACHE II with GCS. The GCS score
was calculated as an independent variable using linear
regression. The R2 of SAPS II was 0.560, and that of
APACHE II was 0.484 (p<0.01), indicating that GCS
can replace more than half the data for SAPS II and
almost half the data for APACHE II.
The total mean mortality ratio was 29.87%. The
mortality rate was > 50% if the patient’s GCS was < 5
(Figure 2). Patients with GCS ≤ 5 had a higher proba-
bility of mortality than patients with GCS>5 (p<0.01).
We also found that patients with GCS-M ≤ 3 had a
higher probability of mortality than patients with
GCS-M > 3 (p < 0.01). But for GCS-E and GCS-V,
patients with scores of 1 had a higher probability of mor-
tality than patients with scores >1 (p<0.01) (Figure 3).
Patients had a higher probability of mortality if GCS
was E1V1M3 (GCS-E=1, GCS-V=1, and GCS-M=3)
or less (p < 0.01).
Discussion
There are many reports discussing the differences be-
tween APACHE II and SAPS II because one or the
other have greater popularity and perceived accuracy
depending on the patient group they are being used in.
Many studies have demonstrated that there is no signif-
icant difference in accuracy between the 2 models.21,22
J Chin Med Assoc • March 2010 • Vol 73 • No 3 141
Good mortality prediction by GCS
Table 1. Demographic characteristics of patients (n = 154)
Female Male Total
Sex (%) 32.5 67.5 100
Mean age (yr) 57.7 56.2 56.7 ± 20.4
Alive/dead (n)
Alive 34 74 108
Dead 17 29 46
Admission type (n)
Medical problem 30 50 80
Scheduled surgery 12 32 44
Emergency surgery 9 21 30
Disease type (n)
ICH/SDH/SAH without surgery 17 32 49
Craniotomy for ICH/SDH/SAH 11 10 21
Head trauma 11 23 34
Multiple trauma 3 7 10
Craniotomy for neoplasm 3 4 7
Neurological organ failure 1 5 6
Non-classified neurological disease 6 21 27
ICH = intracranial hemorrhage; SDH = subdural hemorrhage; SAH = subarachnoid hemorrhage.
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Figure 1. Receiver operating characteristic (ROC) curves of Acute
Physiology and Chronic Health Evaluation II (APACHE II), Simplified
Acute Physiology Score II (SAPS II), and the multiple regression
model of the Glasgow Coma Scale (GCS-mr). The area under the
ROC curve (AUC) of APACHE II is 0.846 and of SAPS II is 0.872.
The AUC of GCS-mr is 0.866 (R2 = 0.389).
But neither mortality prediction model can be applied
to a single patient with good accuracy. Some studies
have suggested that SAPS II performs better than
APACHE II for certain diseases.8,9 Other reports have
the opposite conclusion for other diseases.2,10,11 One of
the most important differences between SAPS II and
APACHE II is that the APACHE II has special disease
calibrations and thus has better mortality prediction
power within different disease groups. This study found
that SAPS II and APACHE II had the same predictive
power in clinical use.
SAPS II has 15 attributes and APACHE II has 12
attributes. APACHE II and SAPS II both contain the
attribute of GCS. Le Gall et al reported that the
weights of the GCS are 17% in APACHE II and 19% in
APACHE III, without disease specificity.4 In the current
study, the GCS score was calculated as an independ-
ent variable using linear regression. The R2 of SAPS
II was 0.560 and that of APACHE II was 0.484
(p < 0.01), clearly indicating that GCS played an impor-
tant role in mortality prediction for the neurological
patients in this study.
APACHE II, III and IV are all good mortality pre-
diction models, but they each have their advantages and
disadvantages.23 There is no significant difference in
prediction power between APACHE II and APACHE
IV. In addition, APACHE IV has more than 40 attrib-
utes and computer aids for prediction.24 Thus, com-
pared with APACHE II and SAPS II, data on many
more attributes need to be collected for APACHE IV.
This study showed that the power of GCS-mr was the
same as that of APACHE II and SAPS II for mortality
prediction. The GCS has only 3 attributes; the GCS-mr
is therefore the most convenient for use in predicting
the mortality of neurosurgical patients.
Elf et al reported that improved treatment for head
injury patients with GCS-M ≥ 4 could increase the
survival rate in the ICU.25 In our study, neurological
patients with GCS≤5 had a high probability of mortal-
ity (p < 0.01). We also found that neurological patients
with GCS-M ≤ 3 had a high probability of mortality
(p < 0.01). Neurological or neurosurgical patients had
a high probability of mortality if GCS was E1V1M3 or
less (p < 0.01). This may be because brain stem injury
was progressing and patients would be in a state of
pathological postural decerebrate and decorticated 
rigidity or none. So both GCS ≤ 5 and GCS-M ≤ 3 
are good indicators for the mortality of neurological
patients.
In conclusion, SAPS II, APACHE II and GCS-mr
have the same predictive power for the mortality of neu-
rosurgical patients. But the GCS-mr is more convenient
to use in such patients. If only for quick reference, both
GCS ≤ 5 and GCS-M ≤ 3 are good indicators for the
disease severity of neurological patients. We suggest that
the GCS-mr can serve as a good mortality prediction
model for neurosurgical patients.
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Figure 3. Mortality ratio by the motor component (GCS-M), eye
component (GCS-E) and verbal component (GCS-V) of the Glasgow
Coma Scale (GCS). The mortality rate is > 50% if GCS-M is ≤ 3.
The mortality rate = 58.46% if GCS-E = 1. The mortality rate =
42.55% if GCS-V = 1. 
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Figure 2. Mortality ratio by Glasgow Coma Scale (GCS). The R2 of
the tendency line is 0.8461. The total mortality rate is 29.87%.
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